glutathione reductase molecualr weight System from Cyanobacteria to Higher Eukaryotes Glutathione Reductase, Human Recombinant
Description
The oral activity seen in rodents cannot be directly mapped to human oral dosing without pharmacokinetic bridging studies, which do not exist for BPC-157
The most common adverse events are gastrointestinal: nausea (occurring in 12-33% of subjects depending on dose), diarrhea, constipation, and decreased appetite
BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening
Ophthalmologic assessment if diabetic retinopathy progression is suspected
